XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $200,929 | +7.0% | 5,882 | +20.6% | 0.00% | – |
Q2 2023 | $187,842 | +13.8% | 4,879 | +5.7% | 0.00% | – |
Q1 2023 | $165,135 | -10.2% | 4,614 | -1.0% | 0.00% | – |
Q4 2022 | $183,822 | +49.4% | 4,662 | +36.1% | 0.00% | – |
Q3 2022 | $123,000 | +61.8% | 3,426 | +38.6% | 0.00% | – |
Q2 2022 | $76,000 | +100.0% | 2,472 | +102.1% | 0.00% | – |
Q1 2022 | $38,000 | -32.1% | 1,223 | -31.2% | 0.00% | – |
Q4 2021 | $56,000 | +250.0% | 1,777 | +73.9% | 0.00% | – |
Q3 2021 | $16,000 | -15.8% | 1,022 | +0.1% | 0.00% | – |
Q2 2021 | $19,000 | +5.6% | 1,021 | +2.1% | 0.00% | – |
Q1 2021 | $18,000 | -33.3% | 1,000 | -41.9% | 0.00% | – |
Q4 2020 | $27,000 | +22.7% | 1,722 | -13.3% | 0.00% | – |
Q3 2020 | $22,000 | -24.1% | 1,986 | -12.7% | 0.00% | – |
Q2 2020 | $29,000 | +314.3% | 2,274 | +259.8% | 0.00% | – |
Q1 2020 | $7,000 | -69.6% | 632 | -63.9% | 0.00% | – |
Q4 2019 | $23,000 | +109.1% | 1,753 | +42.4% | 0.00% | – |
Q3 2019 | $11,000 | -78.4% | 1,231 | -76.0% | 0.00% | – |
Q2 2019 | $51,000 | +70.0% | 5,123 | +70.8% | 0.00% | – |
Q1 2019 | $30,000 | +2900.0% | 3,000 | +1913.4% | 0.00% | – |
Q4 2018 | $1,000 | -90.9% | 149 | -82.6% | 0.00% | – |
Q3 2018 | $11,000 | +37.5% | 854 | -3.9% | 0.00% | – |
Q2 2018 | $8,000 | 0.0% | 889 | -64.9% | 0.00% | – |
Q2 2017 | $8,000 | +60.0% | 2,530 | +310.0% | 0.00% | – |
Q3 2016 | $5,000 | -37.5% | 617 | -44.2% | 0.00% | – |
Q1 2016 | $8,000 | -61.9% | 1,106 | -57.9% | 0.00% | – |
Q4 2015 | $21,000 | +75.0% | 2,629 | +148.5% | 0.00% | – |
Q2 2015 | $12,000 | +100.0% | 1,058 | +205.8% | 0.00% | – |
Q1 2015 | $6,000 | -14.3% | 346 | -7.0% | 0.00% | – |
Q4 2014 | $7,000 | – | 372 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |